Expertise in
3
conditions

Dr. Sanjay Mehta

Orthopedics
Orthopedic Trauma Services LTD
285 E State St Ste 500, 
Columbus, OH 
Referral may be required
Expertise in
3
conditions
Orthopedic Trauma Services LTD
285 E State St Ste 500, 
Columbus, OH 

Overview

Sanjay Mehta is an Orthopedics provider practicing medicine in Columbus, Ohio.

Dr. Mehta is highly rated in 3 conditions, according to our data. His clinical expertise encompasses Infectious Arthritis, Compartment Syndrome, Osteoarthritis, Hip Replacement, and Percutaneous Coronary Intervention (PCI).

He is actively involved in clinical research, co-authoring 195 peer reviewed articles and participating in 9 clinical trials.

Specialties

Orthopedics

Licenses

Orthopaedic Trauma in OH

Hospital Affiliations

Doctors Hospital
Grant Medical Center

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Buckeye Health Plan
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE-MEDICAID PLAN
CareSource
  • HMO
Cigna
  • EPO
  • HMO
  • PPO
Devoted Health
  • MEDICARE MAPD
  • OTHER MEDICARE
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medical Health
  • HMO
  • PPO
Medical Mutual
  • HMO
  • PPO
Oscar
  • EPO
  • HMO
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 8 Less Insurance Carriers -

Locations

Orthopedic Trauma Services LTD
285 E State St Ste 500, Columbus, OH 43215
Other Locations
OhioHealth Corporation
5141 W Broad St Ste 150, Columbus, OH 43228

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

9 Clinical Trials

A Phase 3, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Ralinepag When Added to PAH Standard of Care or PAH Specific Background Therapy in Subjects With WHO Group 1 PAH
A Phase 3, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Ralinepag When Added to PAH Standard of Care or PAH Specific Background Therapy in Subjects With WHO Group 1 PAH
Enrollment Status: Completed
Publish Date: April 14, 2026
Intervention Type: Drug
Study Drug: Ralinepag
Study Phase: Phase 3
An Extended Access Program to Assess Long-term Safety of Bardoxolone Methyl in Patients With Pulmonary Hypertension
An Extended Access Program to Assess Long-term Safety of Bardoxolone Methyl in Patients With Pulmonary Hypertension
Enrollment Status: Terminated
Publish Date: June 11, 2025
Intervention Type: Drug
Study Phase: Phase 3
A Study of the Efficacy and Safety of Bardoxolone Methyl in Patients With Connective Tissue Disease-associated Pulmonary Arterial Hypertension
A Study of the Efficacy and Safety of Bardoxolone Methyl in Patients With Connective Tissue Disease-associated Pulmonary Arterial Hypertension
Enrollment Status: Terminated
Publish Date: June 04, 2025
Intervention Type: Drug
Study Phase: Phase 3
Study of Angiogenic Cell Therapy for Progressive Pulmonary Hypertension: Intervention With Repeat Dosing of eNOS-enhanced EPCs
Study of Angiogenic Cell Therapy for Progressive Pulmonary Hypertension: Intervention With Repeat Dosing of eNOS-enhanced EPCs
Enrollment Status: Terminated
Publish Date: January 31, 2025
Intervention Type: Biological
Study Drug: Autologous EPCs transfected with human eNOS
Study Phase: Phase 2/Phase 3
A Phase 3, Randomized, Double-blind, Placebo-controlled Study of Ralinepag to Evaluate Safety and Effects on Exercise Capacity Assessed by CPET in Subjects With WHO Group 1 Pulmonary Hypertension Who Recently Initiated Therapy
A Phase 3, Randomized, Double-blind, Placebo-controlled Study of Ralinepag to Evaluate Safety and Effects on Exercise Capacity Assessed by CPET in Subjects With WHO Group 1 Pulmonary Hypertension Who Recently Initiated Therapy
Enrollment Status: Terminated
Publish Date: October 24, 2023
Intervention Type: Drug
Study Drug: Ralinepag
Study Phase: Phase 3
Open-Label Extension Study of UT-15C in Subjects With Pulmonary Arterial Hypertension- A Long-Term Follow-Up to Protocol TDE-PH-310
Open-Label Extension Study of UT-15C in Subjects With Pulmonary Arterial Hypertension- A Long-Term Follow-Up to Protocol TDE-PH-310
Enrollment Status: Completed
Publish Date: June 02, 2022
Intervention Type: Drug
Study Drug: UT-15C
Study Phase: Phase 3
Phase 2a Randomized, Single-Blind, Placebo-Controlled, 12-week Escalating Dose Study to Assess the Safety, Tolerability and Clinical Activity of 3 Concentrations of Locally Applied MBN-101 to Infected Bone Sites
Phase 2a Randomized, Single-Blind, Placebo-Controlled, 12-week Escalating Dose Study to Assess the Safety, Tolerability and Clinical Activity of 3 Concentrations of Locally Applied MBN-101 to Infected Bone Sites
Enrollment Status: Completed
Publish Date: September 30, 2021
Intervention Type: Other, Drug
Study Phase: Phase 2
A Phase 2a, Double-Blind, Placebo-Controlled Multicenter Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamic Effects of RVT-1201 in Patients With Pulmonary Arterial Hypertension
A Phase 2a, Double-Blind, Placebo-Controlled Multicenter Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamic Effects of RVT-1201 in Patients With Pulmonary Arterial Hypertension
Enrollment Status: Terminated
Publish Date: March 09, 2020
Intervention Type: Drug
Study Phase: Phase 2
A Phase III, International, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Clinical Worsening Study of UT-15C in Subjects With Pulmonary Arterial Hypertension Receiving Background Oral Monotherapy
A Phase III, International, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Clinical Worsening Study of UT-15C in Subjects With Pulmonary Arterial Hypertension Receiving Background Oral Monotherapy
Enrollment Status: Completed
Publish Date: February 13, 2020
Intervention Type: Drug
Study Phase: Phase 3
View 8 Less Clinical Trials

195 Total Publications

Successful Control of Refractory Coccidioides Meningitis With MAT2203.
Successful Control of Refractory Coccidioides Meningitis With MAT2203.
Journal: Open forum infectious diseases
Published: November 25, 2025
Similar Doctors
Expertise in
27
conditions
Dr. Thomas Scharschmidt
Orthopedics
Expertise in
27
conditions
Dr. Thomas Scharschmidt
Orthopedics

The Osuccc-James

460 W 10th Ave, 
Columbus, OH 
 (2.8 miles away)
800-293-5066
Languages Spoken:
English
See accepted insurances

Thomas Scharschmidt is an Orthopedics provider practicing medicine in Columbus, Ohio. Dr. Scharschmidt is highly rated in 27 conditions, according to our data. His clinical expertise encompasses Adult Soft Tissue Sarcoma, Bone Tumor, Ewing Sarcoma, Hip Replacement, and Laminectomy.

Expertise in
26
conditions
Dr. Joel Mayerson
Orthopedics
Expertise in
26
conditions
Dr. Joel Mayerson
Orthopedics

The Arthur G. James Cancer Hospital And Richard J. Solove Research Institute

460 W 10th Ave, 
Columbus, OH 
 (2.8 miles away)
800-293-5066
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Joel Mayerson is an Orthopedics provider practicing medicine in Columbus, Ohio. Dr. Mayerson is highly rated in 26 conditions, according to our data. His clinical expertise encompasses Adult Soft Tissue Sarcoma, Bone Tumor, Ewing Sarcoma, Hip Replacement, and Osteotomy.

Expertise in
8
conditions
Dr. Adolph Lombardi
Orthopedics
Expertise in
8
conditions
Dr. Adolph Lombardi
Orthopedics

Joint Implant Surgeons Inc.

7277 Smiths Mill Rd Ste 200, 
New Albany, OH 
 (13.3 miles away)
740-633-4312
Languages Spoken:
English
See accepted insurances

Adolph Lombardi is an Orthopedics provider practicing medicine in New Albany, Ohio. Dr. Lombardi is highly rated in 8 conditions, according to our data. His clinical expertise encompasses Osteoarthritis, Acute Pain, Arthritis, Knee Replacement, and Hip Replacement.

Frequently Asked Questions about Dr. Sanjay Mehta

How do I make an appointment with Dr. Sanjay Mehta?

You can book an appointment with Dr. Sanjay Mehta by calling their office at 614-566-7777. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Sanjay Mehta a top-rated expert for Infectious Arthritis?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Sanjay Mehta is classified as an Advanced expert for Infectious Arthritis, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Sanjay Mehta specialize in?

While Dr. Sanjay Mehta is a Orthopedics, they have specific expertise in Infectious Arthritis, Hip Replacement, and Compartment Syndrome. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Orthopedics.

Does Dr. Sanjay Mehta participate in research or clinical trials?

Yes. Dr. Sanjay Mehta has published 195 articles and abstracts on conditions like Infectious Arthritis. You can view a list of Dr. Sanjay Mehta's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Sanjay Mehta accept my insurance?

Dr. Sanjay Mehta accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 614-566-7777 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Mehta's expertise for a condition
ConditionClose
      View All 9 Experienced Conditions
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile